FDC Limited (BOM:531599)
427.55
+23.85 (5.91%)
At close: May 27, 2026
FDC Limited Revenue
In the fiscal year ending March 31, 2026, FDC Limited had annual revenue of 22.84B INR with 8.36% growth. FDC Limited had revenue of 6.35B in the quarter ending March 31, 2026, with 29.03% growth.
Revenue
22.84B
Revenue Growth
+8.36%
P/S Ratio
3.05
Revenue / Employee
3.33M
Employees
6,857
Market Cap
69.61B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 22.84B | 1.76B | 8.36% |
| Mar 31, 2025 | 21.08B | 1.65B | 8.50% |
| Mar 31, 2024 | 19.43B | 1.59B | 8.92% |
| Mar 31, 2023 | 17.84B | 2.56B | 16.74% |
| Mar 31, 2022 | 15.28B | 1.95B | 14.61% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Viyash Scientific | 34.20B |
| Unichem Laboratories | 22.65B |
| Morepen Laboratories | 17.87B |
| Sanofi India | 17.74B |
| Hikal | 17.46B |
| Rubicon Research | 15.98B |
| CORONA Remedies | 14.03B |
| Procter & Gamble Health | 13.49B |
FDC Limited News
- 9 days ago - FDC Limited receives US FDA ANDA approval for Cefixime Oral Suspension — opens new revenue line in US antibiotic market - Business Upturn
- 2 months ago - FDC reconstitutes board committees and appoints Mohan Chandavarkar as chairman - Business Upturn
- 8 months ago - FDC receives ANDA approval from U.S. FDA for Pilocarpine Hydrochloride Ophthalmic Solution USP - Business Upturn
- 1 year ago - FDC shares drop over 3% as Q4 EBITDA falls 4.2% YoY to Rs 54 crore, net profit down 16.4% YoY - Business Upturn
- 1 year ago - FDC receives US FDA approval for Cefixime 400 mg tablets - Business Upturn
- 1 year ago - FDC shares surge 11%, leading gains in BSE Healthcare index - Business Upturn